+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proton Therapy Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 180 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941129

Global Proton Therapy Market Outlook

The global proton therapy market size was valued at USD 831.7 million in 2023, driven by increased cancer prevalence across the globe. The market size is anticipated to grow at a CAGR of 11.8% during the forecast period of 2024-2032 to achieve a value of USD 2249 million by 2032.

Proton Therapy: Introduction

Proton therapy is an advanced form of radiation treatment that uses high-energy proton beams to destroy cancer cells. Unlike traditional radiation therapy, proton therapy precisely targets tumors, minimizing damage to surrounding healthy tissues and organs. This precision reduces potential side effects and is especially beneficial for treating cancers in sensitive or hard-to-reach areas. Proton therapy's targeted approach makes it a preferred option for pediatric cancers and cancers located close to vital structures.

Key Trends in the Global Proton Therapy Market

Proton therapy is gaining popularity as a preferred form of radiation treatment due to its precision and minimal damage to surrounding healthy tissues. It's especially favored for treating cancers in sensitive areas and pediatric cases.

Innovations in proton therapy equipment, such as compact and cost-effective systems, are making this technology more accessible and affordable. This includes developments in pencil beam scanning technology, which allows for more precise tumor targeting.

There's a growing trend of integrating AI with proton therapy for treatment planning and optimizing therapy sessions, enhancing the precision and effectiveness of treatments.

The number of proton therapy centers is increasing globally, making this advanced cancer treatment more accessible to patients worldwide.

Strategic collaborations between healthcare providers, research institutions, and technology companies are fostering advancements in proton therapy, driving innovation, and expanding market reach.

Global Proton Therapy Market Segmentation

Market Breakup by Product Type

  • Systems
  • Accelerators
  • Cyclotrons
  • Synchrotrons
  • Beam Delivery
  • Pencil Beam Scanning
  • Passive Scattering
  • Uniform Scanning
  • Modulators
  • Others
  • Software
  • Services

Market Breakup by Components

  • Proton Accelerator
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
  • Linacs
  • H-Minus Synchrotrons
  • Separated Sector Cyclotrons
  • Super-Conducting Cyclotrons
  • Fast Cycling Synchrotron
  • Beam Delivery System
  • The Passive Scattering Technique
  • Beam Scanning
  • Nozzle
  • Pencil Scanning Nozzle
  • Single Scattering
  • Double Scattering
  • Uniform Scanning Nozzle
  • Image Viewers
  • Beam Transport System
  • Patient Positioning System (PPS)

Market Breakup by Type

  • Rotating Proton Therapy Systems
  • Non-Rotating Proton Therapy Systems

Market Breakup by Set-Up Systems

  • Multi-Room Systems
  • Single-Room Systems

Market Breakup by Applications

  • Treatment Applications
  • Ediatric Cancer
  • Tumours in the Base of the Skull
  • Prostate Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Lung Cancer
  • Tumours Affecting Spine
  • Eye Melanoma
  • Lymphoma
  • Pituitary Gland Tumours
  • Others
  • Research Applications

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Cancer Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Proton Therapy Market Overview

North America leads in the adoption of proton therapy due to advanced healthcare infrastructure, high healthcare spending, and significant investment in cancer research. The United States is home to a large number of proton therapy centers.

Europe shows strong growth with comprehensive healthcare systems and a focus on advanced cancer treatment solutions. Countries like Germany, the UK, and France are investing in the expansion of proton therapy facilities.

Asia-Pacific experiences rapid growth, driven by increasing healthcare expenditure, rising prevalence of cancer, and growing investment in advanced medical technologies. Countries like Japan, China, and South Korea are rapidly adopting proton therapy and investing in new facilities.

Latin America is an emerging market with increasing awareness of advanced cancer treatment options and improving healthcare infrastructure. The adoption of proton therapy is gradually growing in the region.

The Middle East & Africa shows gradual growth with increasing investment in healthcare infrastructure and a rising focus on advanced medical treatments, including cancer therapy.

Global Proton Therapy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Varian Medical Systems, Inc.
  • IBA Group
  • Hitachi, Ltd.
  • Mevion Medical Systems, Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Optivus Proton Therapy, Inc.
  • ProTom International, Inc.
  • Advanced Oncotherapy Plc.
  • ProNova Solutions, LLC
  • Mitsubishi Electric Corporation


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Proton Therapy Market Overview
3.1 Global Proton Therapy Market Historical Value (2017-2023)
3.2 Global Proton Therapy Market Forecast Value (2024-2032)
4 Global Proton Therapy Market Landscape
4.1 Global Proton Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Proton Therapy Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Proton Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Proton Therapy Market Segmentation
6.1 Global Proton Therapy Market by Product Type
6.1.1 Market Overview
6.1.2 Systems
6.1.2.1 Accelerators
6.1.2.1.1 Cyclotrons
6.1.2.1.2 Synchrotrons
6.1.2.2 Beam Delivery
6.1.2.2.1 Pencil Beam Scanning
6.1.2.2.2 Passive Scattering
6.1.2.2.3 Uniform Scanning
6.1.2.3 Modulators
6.1.2.4 Others
6.1.3 Software
6.1.4 Services
6.2 Global Proton Therapy Market by Components
6.2.1 Market Overview
6.2.2 Proton Accelerator
6.2.2.1 Cyclotrons
6.2.2.2 Synchrotrons
6.2.2.3 Synchrocyclotrons
6.2.2.4 Linacs
6.2.2.5 H-Minus Synchrotrons
6.2.2.6 Separated Sector Cyclotrons
6.2.2.7 Super-Conducting Cyclotrons
6.2.2.8 Fast Cycling Synchrotron
6.2.3 Beam Delivery System
6.2.3.1 The Passive Scattering Technique
6.2.3.2 Beam Scanning
6.2.4 Nozzle
6.2.4.1 Pencil Scanning Nozzle
6.2.4.2 Single Scattering
6.2.4.3 Double Scattering
6.2.4.4 Uniform Scanning Nozzle
6.2.5 Image Viewers
6.2.6 Beam Transport System
6.2.7 Patient Positioning System (PPS)
6.3 Global Proton Therapy Market by Type
6.3.1 Market Overview
6.3.2 Rotating Proton Therapy Systems
6.3.3 Non-Rotating Proton Therapy Systems
6.4 Global Proton Therapy Market by Set-Up Systems
6.4.1 Market Overview
6.4.2 Multi-Room Systems
6.4.3 Single-Room Systems
6.5 Global Proton Therapy Market by Applications
6.5.1 Market Overview
6.5.2 Treatment Applications
6.5.2.1 Ediatric Cancer
6.5.2.2 Tumours In the Base of The Skull
6.5.2.3 Prostate Cancer
6.5.2.4 Head and Neck Cancer
6.5.2.5 Breast Cancer
6.5.2.6 Lung Cancer
6.5.2.7 Tumours Affecting Spine
6.5.2.8 Eye Melanoma
6.5.2.9 Lymphoma
6.5.2.10 Pituitary Gland Tumours
6.5.2.11 Others
6.5.3 Research Applications
6.6 Global Proton Therapy Market by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Ambulatory Surgical Centers
6.6.4 Cancer Research Institutes
6.6.5 Others
6.7 Global Proton Therapy Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Proton Therapy Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Proton Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Proton Therapy Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Proton Therapy Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Proton Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Varian Medical Systems, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 IBA Group
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Hitachi, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Mevion Medical Systems, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Sumitomo Heavy Industries, Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Optivus Proton Therapy, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 ProTom International, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Advanced Oncotherapy Plc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 ProNova Solutions, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Mitsubishi Electric Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Proton Therapy Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Varian Medical Systems Inc.
  • IBA Group
  • Hitachi Ltd
  • Mevion Medical Systems Inc.
  • Sumitomo Heavy Industries Ltd
  • Optivus Proton Therapy Inc.
  • ProTom International Inc.
  • Advanced Oncotherapy Plc.
  • ProNova Solutions LLC
  • Mitsubishi Electric Corporation

Methodology

Loading
LOADING...

Table Information